Cardioactive Steroid Toxicity


Article Author:
Muhammed Ershad


Article Editor:
Muhammad Khalid


Editors In Chief:
Russell McAllister
Jason Widrich
Daniel Sizemore


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
3/19/2019 1:01:51 AM

Introduction

Cardioactive steroids (CAS) are medically important compounds historically used for conditions like edema and "dropsy." There is literature from the 17th century regarding their therapeutic effects. They are available in several plants including oleander, foxglove, lily of the valley, red squill, dogbane, common milkweed plant, etc. Leaves of Digitalis lanata contain digoxin while seeds of Digitalis purpurea may contain digitalin. Several Chinese herbal medications and aphrodisiacs may also contain cardioactive steroids. Historians believe the selection of yellow contrast in Van Gogh's painting was likely secondary to digitalis toxicity.

Digoxin is the most well known cardioactive steroid with application in the treatment of congestive heart failure and for the control of ventricular rate in atrial tachyarrhythmias. It is available in tablet form and liquid filled capsules that can increase its bioavailability. Other less commonly used cardioactive steroids include lanatoside C, digitoxin, ouabain, gitalin, and deslanoside.

Etiology

Digoxin toxicity manifests itself in acute and chronic form. Acute toxicity is mainly the result of dosage errors, suicidal ingestions and accidental ingestion of CAS containing plants. Chronic toxicity is usually due to drug-drug interactions, conditions that alter the protein binding resulting in increased free state CAS, changes in gut absorption of the drug, and impaired renal clearance of the drug. The usual victims of CAS toxicity as extremes of age and those with renal insufficiency issues. 

CAS toxicity may also result from ingestion of certain plants and animal products. Some plants that are known for this include Nerium oleander, lily of the valley, foxglove, and red squill. There are many tea and herbal products in the market that can potentially cause CAS toxicity.[1][2][3]  Bufo toad secretions used as aphrodisiacs contain bufotoxin that may cause toxicity by oral ingestion.[4][5] Ch'an Su, a herbal medicine used in congestive heart failure contain bufadienolides, is also arrhythmogenic and can cause similar toxicity.

Epidemiology

Digoxin toxicity is a worldwide phenomenon because it has therapeutic applications. Additionally, epidemics and sporadic cases have also been reported secondary to consumption of oleander plants. The 2011 Annual report of the American Poison Control Center described 1376 cases of cardiac glycoside poisoning. Multiple reports exist of Yellow oleander leaves poisoning in India and Sri Lanka.[6][7][8] Cerbera manghas fruits are also in use by populations in south India and Sri Lanka resulting in reported fatal self-poisonings.[8]

Pathophysiology

The chemical structure of a CAS contains a steroid nucleus and a 5 or 6-membered lactone ring. Cardenolides, which are 5-membered rings, are mostly from plants, while, Bufadienolides, with a 6-membered ring, are mainly animal based.[9] Digitoxin and Digoxin, extracted from foxglove, belong to Cardenolides while bufadienolides like bufalin derive from mammals, amphibians, a few insects (lighting bug, Photinus spp.), and plant sources (red quill).[10] 

CAS are primarily used as inotropic agents in therapeutic settings. Apart from myocytes, they also have effects on vascular smooth muscle and sympathetic nervous system. The primary mechanism of action is the reversible inhibition of the sodium-potassium ATPase pump, which leads to increased intracellular sodium and decreased intracellular potassium levels, leading to inactivation of sodium-calcium anti-porter pump, which in turn causes an accumulation of calcium intracellularly. This accumulation of intracellular calcium consequently triggers further calcium release from the sarcoplasmic reticulum and finally causes increased myocardial contractility. Besides increased inotropy, CAS causes increased vagal tone in SA and AV nodes decreasing conduction in the nodes with a decreased duration of the refractory period which increases the risk of automaticity and arrhythmias.

Toxicokinetics

Digoxin and Digitoxin are the two main cardioactive steroids used in practice. Both have differences in their kinetics; digitoxin is more readily absorbed, more protein bound, and with a lower volume of distribution. Digitoxin clears out mostly by hepatic metabolism (80%) whereas digoxin gets eliminated through the renal route.[11] Considering that both the medications have a narrow therapeutic index, dose adjustments are critical, to titrate for any changes in factors affecting absorption, metabolism, protein binding, tissue distribution or elimination. Drugs like quinidine decrease the renal clearance of digoxin by inhibiting the tubular secretion of digoxin, leading to increased plasma levels. Other drugs that might increase digoxin levels include amiodarone, spironolactone, diltiazem, carvedilol, and verapamil. 

Eubacterium lentum, an enteric bacteria in gastrointestinal tract inhibits digoxin absorption. Antibiotics that may inhibit the growth of these regulatory bacteria in the gut may cause increased digoxin absorption.

History and Physical

The signs and symptoms of CAS toxicity can be similar in both acute and chronic CAS toxicity although it can be more subtle and challenging with chronic CAS toxicity. The clinical manifestations divide into cardiac and non-cardiac.

Non-cardiac manifestations

In acute toxicity, there may be an asymptomatic period of minutes to hours. Gastrointestinal symptoms including nausea, vomiting, or abdominal pain are often the earliest symptoms to occur. Neurological symptoms may range from generalized weakness to overt confusion. In chronic toxicity, the symptoms are more insidious and neurological symptoms including lethargy, disorientation, drowsiness, headache, hallucinations, and rarely convulsions may occur. Visual symptoms like diplopia, photophobia, scotomata, photopsia, and color vision disturbances such as xanthopsia may also be an indicator of chronic toxicity. 

While acute toxicity may cause electrolyte disturbance, hyperkalemia has prognostic implications in CAS toxicity. Potassium levels more than 5.5 mEq/L associated with 100% mortality while levels between 5.0-5.5 have links with 50% mortality.[12] Interestingly, hyperkalemia is only a marker of worse outcomes in CAS toxicity and correction of the hyperkalemia alone does not improve the survival. 

Cardiac manifestations 

With CAS poisoning, virtually any arrhythmia can occur because of the AV node blocking properties of CAS. Increased automaticity combined with impaired conduction through SA or AV node should lead a physician to suspect CAS toxicity. Bidirectional ventricular tachycardia with alternating QRS axis is almost pathognomic for CAS toxicity although it may also occur with aconitine toxicity and familial catecholaminergic polymorphic VT.[13][14]

In younger healthier individuals, accentuation of vagal effects manifesting as bradydysrhythmias is more common. In older people with cardiac disease, however, ventricular dysrhythmias and ectopy are more common. AV junctional blockade combined with increased ventricular automaticity is the most commonly seen arrhythmia in CAS toxicity.[15]

In patients on chronic digoxin therapy, ECG may show scooped ST-segment depression also known as Salvador Dali's mustache appearance, T-wave inversions or flattening, QT shortening and increased U wave amplitude. These features suggest long-term digoxin use rather than acute toxicity.

Evaluation

In acute ingestion, digoxin/digitoxin levels should be obtained at the time of presentation and more than six hours after the time of ingestion. Given the distribution phase, levels six hours post-ingestion better correlate with digoxin effects. For patients suspected of chronic toxicity, one level should suffice.  Levels above 2 ng/ml for digoxin and above 40 ng/ml for digitoxin 6 hours after the last dose are often clinically toxic.

Electrolytes should be checked early to look for hyperkalemia. Prompt determination of hypokalemia and hypomagnesemia is crucial as they may contribute to cardiac toxicity. Assessment of renal function is of paramount importance given the renal clearance. In addition to basic lab workup, acetaminophen levels should be checked in cases involving intentional ingestion since acetaminophen among the most common over-the-counter medication and the toxicity associated with it is initially subtle. Serial EKGs and cardiac monitoring should be performed to detect arrhythmias early and treat as it occurs.

Treatment / Management

As with any other case of acute overdose, initial management involves stabilizing airway, breathing, and circulation. Given rapid gastrointestinal absorption, decontamination should is a consideration if the patient presents early.  Monitoring and treating arrhythmias, electrolyte imbalances, measuring the digoxin concentration and definitive care which includes administering digoxin-specific antibody fragments are the cornerstone steps in managing acute overdoses. 

Gastrointestinal decontamination

Activated charcoal administration is possible if the patient presents within 1 to 2 hours of acute ingestion, provided the patient is alert and is protecting the airway. Multidose activated charcoal can also be a consideration since both digoxin and digitoxin undergo enterohepatic circulation. The dose is 1 mg/kg orally that can be repeated every 2 to 4 hours up to four times. This regimen reduces the serum concentration of CAS by preventing enterohepatic circulation. Cholestyramine and colestipol may also help in decreasing the gastrointestinal reabsorption of digoxin, as a result of their steroid binding capacity.

Antidotal therapy with Digoxin-specific antibody fragments

Early recognition of CAS toxicity and expeditious administration of digoxin antibody fragments is vital in managing acute overdoses. The indications for administration of antibody fragments include:

1) Life-threatening dysrhythmias.

2) Potassium of over 5 mEq/L in acute ingestions.

3) Non-digoxin cardioactive steroid toxicity.

4) Chronic digoxin toxicity with arrhythmias, altered mental status or significant GI symptoms. 

5) Digoxin levels over 10ng/ml 6hrs post ingestion or 15 at any time during the course.

Asymptomatic patients with an elevated digoxin level is not an indication for starting antibody fragment.[16]

The dose of DigFab to be given depends on the availability of information regarding how much digoxin was ingested and if the digoxin levels in the blood are available. 

a) If neither the quantity ingested nor the digoxin levels are available, an empiric dose of 10 vials of digoxin immune fab is an option. In children, five vials are permissible. In very small children, be cautious of volume overload. 

b) If the quantity ingested is known but not the levels, the number of vials of DigFab can be calculated by the following formula:

Number of vials = Dose ingested (in mg) x 1.6

 c) If the levels of digoxin are known, then the number of vials to be given is derived by the following formula:

Number of vials = [(serum digoxin concentration in ng/mL) (patient's weight in kg)]/ 100

 When the formulae are used to calculate the number of vials, round up the result to the nearest whole number.

When CAS other than digoxin and digitoxin is the toxin concerned, the empiric administration of 10 vials for adults and five vials for children is the recommended therapeutic approach. 

Electrolyte Imbalances 

Hyperkalemia is an indicator of the severity of CAS toxicity. Both hyper and hypokalemia may potentiate digoxin toxicity. Hyperkalemia itself does not cause death, and its correction does not improve survival. Anti-hyperkalemic measures including insulin/dextrose administration should be judiciously used to avoid hypokalemia. Anti hyperkalemic measures along with digoxin immune fab can lead to hypokalemia as the reactivated Na-K-ATPase pump will draw the potassium into the intracellular compartment. 

If hypokalemia exists, this needs to be corrected early as hypokalemia further exacerbates digoxin toxicity. Patients with hypokalemia may have underlying hypomagnesemia that needs repletion. Calcium administration for hyperkalemia had been traditionally discouraged in digoxin toxicity for concerns of "stone-heart."[17][18] However, recent literature contradicts "stone-heart" theory and suggests that it is safe to use calcium in digoxin overdose.[19][20][21]

General Management

If Fab fragments are not immediately available, symptomatic bradycardia or bradyarrhythmia may are treatable with atropine (0.5 mg IV in adults; 0.02 mg/kg IV in children, minimum dose 0.1 mg) and hypotension can be treated with Intravenous fluids. Lidocaine and phenytoin may be useful for the management of ventricular tachyarrhythmias secondary to cardioactive steroids.  

Volume depletion secondary to GI losses, decreased oral intake, or concomitant use of diuretics can decrease renal clearance of digoxin and lead to toxicity. Correction of the volume deficit by judicious fluid depletion, improving oral intake in patients with poor oral intake and reviewing the patient's medications that can contribute to volume depletion (diuretics, laxatives, etc.) are important steps in the management of the condition.  

Disposition

All patients with signs and symptoms of digoxin toxicity should be admitted to the hospital with continuous cardiac monitoring. Those with lethal arrhythmias, unstable vitals or clinically significant comorbidities should be admitted to an intensive care unit. 

Serial digoxin and potassium levels should be checked along with EKG monitoring to identify arrhythmias. The frequency of EKG monitoring may be increased if there are abnormalities. 

Cardiac monitoring for at least 6 hours is the recommended interval for patients who have suspected CAS toxicity but are otherwise asymptomatic with a normal exam and labs. If repeat digoxin levels are down trending and the clinical course is improving, they may be safely discharged with follow-up instructions. 

Differential Diagnosis

There are toxicological and nontoxicological conditions that can potentially mimic digoxin toxicity. 

Toxicological causes include calcium channel blocker, beta blocker, and clonidine overdose which can present with bradycardia and hypotension, similar to digoxin overdose. Elevated digoxin levels will help in narrowing it down to digoxin toxicity. Hyperglycemia is seen with a calcium channel blocker overdose, whereas clonidine overdose has features of respiratory depression, CNS depression, and miosis. These features, however, should not be solely used to rule out digoxin toxicity.

Non-toxicology causes include hypothermia, hypothyroidism, myocardial infarction, sick sinus syndrome, and hyperkalemia.

Patients with reduced renal clearance, volume expanded conditions, and increased inotropic need may have high digoxin levels secondary to endogenous digoxin-like immunoreactive substances (DLIS) that cross-react with digoxin assay. There are reports of exogenous DLIS after ingestion of spironolactone, potassium canrenone, and certain Chinese medicines. Exogenous and endogenous DLIS interfere in the digoxin serum concentration, and this can be overcome by monitoring digoxin concentration in the protein-free ultrafiltrates.  

Prognosis

The prognosis for patients with digoxin toxicity who receive appropriate treatment appropriately is good. Hyperkalemia is an important prognostic indicator. In a retrospective study of patients with digoxin toxicity, all patients with potassium levels above 5.5 mEq/L died whereas no patient died in the group with potassium levels less than 5 mEq/L. The mortality was 50% when the potassium levels were between 5-5.5 mEq/L.[12] Patients who present with chronic digoxin toxicity and remain untreated, have mortality ranging from 5 to 13%.[22] The increasing serum digoxin levels have associations with increased mortality. 

Complications

VIgilence for cardiac arrhythmias and electrolyte imbalances is necessary. Any cardiac arrhythmia is visible with CAS overdose secondary to the AV node blocking effects of CAS. Electrolyte imbalances include hyperkalemia, hypokalemia, and hypomagnesemia. CNS depression may also occur either due to the direct toxic effects of CAS or due to the generalized cerebral hypoperfusion. Although rare but mesenteric ischemia can also occur.[23]

Deterrence and Patient Education

Patients should be appropriately educated by the caring physician or the clinical pharmacist before starting long-term digoxin therapy. Such patients are at risk of accidental overdoses and drug-drug interactions. Patients should be instructed not to take a "make-up dose" in case of missing a dose if the next scheduled dose is to be within 12 hours. 

Children and their parents should be made aware of the toxic nature of plants such as Nerium oleander and Lily of the Valley.

Enhancing Healthcare Team Outcomes

The management of CAS toxicity requires teamwork. Physicians involved in managing these cases should take expert advice of a toxicologist or a poison control center. Initial management should involve:

  1. Management of airway, breathing, circulation, and gastrointestinal decontamination, if needed.
  2. A complete history on the substance ingested, any co-ingestion, time of ingestion, any suicidal intent behind the ingestion and any previous similar history in the past.
  3. The ordering of initial investigations including digoxin levels, electrolytes, renal function tests, and electrocardiogram.
  4. Prompt correction of any electrolyte abnormalities.
  5. If the patient is stable enough, and the ingestion is acute with suicidal intent, getting a psychiatric history to assess the risk of self-harm if any. If it is chronic toxicity, obtaining a detailed history of the digoxin dosage and frequency of intake, a list of other active medications, and any comorbidities that may coexist including renal insufficiency and congestive cardiac failure, may be fruitful. 
  6. Consult with toxicology or a poison control center about further management of the patient.
  7. Consult with a pharmacist about the calculation of the dosage of digoxin immune fab.

The management of digoxin toxicity should continue after the patient is admitted to an appropriate level of care. Patients should be admitted to an ICU level of care for life-threatening electrolyte imbalances or arrhythmias, or if the presumed clinical course of the patient is predicted to worsen based on the dose of digoxin consumed or the blood level. Symptomatic but otherwise stable patients may receive therapy on a general medical floor. Asymptomatic patients may undergo observation for 6 hours in the emergency department.

The admitting team shall continue therapeutic interventions initiated in the emergency department in conjunction with the medical toxicologist. Consult with a mental health counselor or psychiatrist to assess the risk of self-harm and the potential need for psychiatric admission in intentional or self-injurious exposures.


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Cardioactive Steroid Toxicity - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following is not an indication for starting digoxin immune fab in a patient with digoxin toxicity?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following plants have cardiac glycoside activity?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 17-year-old female was brought to the emergency department by her father after she had ingested around 20 tablets of his "heart failure" medication as an act of self-harm. She appeared lethargic, complaining of abdominal pain, vomiting and colored halos in her vision. Vital signs showed heart rate of 40/min, blood pressure of 90/60 mmHg, respiratory rate of 18/min, EKG showed complete heart block with frequent premature ventricular complexes. Labs showed hyperkalemia. Which of the following is the mechanism of toxicity of the medication involved?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following can be a possible trigger for acute on chronic digoxin toxicity in patients on long-term digoxin therapy?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Regarding pharmacokinetics of digoxin toxicity, which of the following is a true statement?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Cardioactive Steroid Toxicity - References

References

Barrueto F Jr,Kirrane BM,Cotter BW,Hoffman RS,Nelson LS, Cardioactive steroid poisoning: a comparison of plant- and animal-derived compounds. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2006 Dec     [PubMed]
Eisner T,Goetz MA,Hill DE,Smedley SR,Meinwald J, Firefly     [PubMed]
Barrueto F Jr,Jortani SA,Valdes R Jr,Hoffman RS,Nelson LS, Cardioactive steroid poisoning from an herbal cleansing preparation. Annals of emergency medicine. 2003 Mar     [PubMed]
Brustbauer R,Wenisch C, [Bradycardiac atrial fibrillation after consuming herbal tea]. Deutsche medizinische Wochenschrift (1946). 1997 Jul 25     [PubMed]
McRae S, Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 1996 Aug 1     [PubMed]
Chern MS,Ray CY,Wu DL, Biologic intoxication due to digitalis-like substance after ingestion of cooked toad soup. The American journal of cardiology. 1991 Feb 15     [PubMed]
Jan SL,Chen FL,Hung DZ,Chi CS, Intoxication after ingestion of toad soup: report of two cases. Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui. 1997 Nov-Dec     [PubMed]
Eddleston M,Ariaratnam CA,Meyer WP,Perera G,Kularatne AM,Attapattu S,Sheriff MH,Warrell DA, Epidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in northern Sri Lanka. Tropical medicine     [PubMed]
Bose TK,Basu RK,Biswas B,De JN,Majumdar BC,Datta S, Cardiovascular effects of yellow oleander ingestion. Journal of the Indian Medical Association. 1999 Oct     [PubMed]
Eddleston M,Haggalla S, Fatal injury in eastern Sri Lanka, with special reference to cardenolide self-poisoning with Cerbera manghas fruits. Clinical toxicology (Philadelphia, Pa.). 2008 Sep     [PubMed]
Smith TW, Pharmacokinetics, bioavailability and serum levels of cardiac glycosides. Journal of the American College of Cardiology. 1985 May     [PubMed]
Bismuth C,Gaultier M,Conso F,Efthymiou ML, Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clinical toxicology. 1973     [PubMed]
Mahdyoon H,Battilana G,Rosman H,Goldstein S,Gheorghiade M, The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. American heart journal. 1990 Nov     [PubMed]
Chan BS,Buckley NA, Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clinical toxicology (Philadelphia, Pa.). 2014 Sep-Oct     [PubMed]
SHRAGER MW, Digitalis intoxication; a review and report of forty cases, with emphasis on etiology. A.M.A. archives of internal medicine. 1957 Dec     [PubMed]
Nola GT,Pope S,Harrison DC, Assessment of the synergistic relationship between serum calcium and digitalis. American heart journal. 1970 Apr     [PubMed]
Fenton F,Smally AJ,Laut J, Hyperkalemia and digoxin toxicity in a patient with kidney failure. Annals of emergency medicine. 1996 Oct     [PubMed]
Van Deusen SK,Birkhahn RH,Gaeta TJ, Treatment of hyperkalemia in a patient with unrecognized digitalis toxicity. Journal of toxicology. Clinical toxicology. 2003     [PubMed]
Levine M,Nikkanen H,Pallin DJ, The effects of intravenous calcium in patients with digoxin toxicity. The Journal of emergency medicine. 2011 Jan     [PubMed]
Ordog GJ,Benaron S,Bhasin V,Wasserberger J,Balasubramanium S, Serum digoxin levels and mortality in 5,100 patients. Annals of emergency medicine. 1987 Jan     [PubMed]
Weil J,Sen Gupta R,Herfarth H, Nonocclusive mesenteric ischemia induced by digitalis. International journal of colorectal disease. 2004 May     [PubMed]
Smith SW,Shah RR,Hunt JL,Herzog CA, Bidirectional ventricular tachycardia resulting from herbal aconite poisoning. Annals of emergency medicine. 2005 Jan     [PubMed]
Priori SG,Napolitano C,Memmi M,Colombi B,Drago F,Gasparini M,DeSimone L,Coltorti F,Bloise R,Keegan R,Cruz Filho FE,Vignati G,Benatar A,DeLogu A, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002 Jul 2     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Anesthesiology. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Anesthesiology, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Anesthesiology, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Anesthesiology. When it is time for the Anesthesiology board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Anesthesiology.